PMID- 19719987 OWN - NLM STAT- MEDLINE DCOM- 20100107 LR - 20131121 IS - 0253-3758 (Print) IS - 0253-3758 (Linking) VI - 37 IP - 2 DP - 2009 Feb TI - [Association of serum uric acid, plasma NT-proBNP, Hs-C reactive protein and invasive hemodynamic parameters in patients with heart failure]. PG - 126-9 AB - OBJECTIVE: To explore the correlation of serum uric acid, invasive hemodynamic parameters, plasma N-terminal proBNP (NT-proBNP) and Hs-C reactive protein (Hs-CRP) in patients with heart failure. METHOD: Invasive hemodynamic parameters derived from Swan-Ganz catheter, serum uric acid, plasma NT-proBNP and Hs-CRP within 12 hours after hospital admission were analyzed in 141 patients with chronic heart failure [New York Heart Association (NYHA) class II-IV]. RESULTS: Incidence of hyperuricemia was 55.30% in this patient cohort. Pulmonary capillary wedge pressure (PCWP) and plasma NT-proBNP in hyperuricemia patients were significantly higher than those in non-hyperuricemia patients (P < 0.01). The percentages of high plasma NT-proBNP (> 600 pmol/L) and hyperuricemia were significantly higher in patients with PCWP > or = 18 and < 28 mm Hg (1 mm Hg = 0.133 kPa) and patients with PCWP > or = 28 mm Hg compared those in patients with PCWP < 18 mm Hg, (P = 0.01, P = 0.02; P < 0.01, P < 0.01, respectively). Partial correlation analysis showed that serum uric acid correlated with right atrial pressure, right ventricular pressure, pulmonary arterial pressure and PCWP (r = 0.19, P = 0.03; r = 0.45, P < 0.01; r = 0.23, P = 0.01; r = 0.24, P = 0.01, respectively). Multiple linear regression analysis showed both serum uric acid and plasma NT-proBNP correlated independently with PCWP (beta = 0.24, P = 0.01; beta = 0.47, P < 0.01, respectively) while plasma Hs-CRP and left ventricular ejection fraction were not correlated with serum uric acid and PCWP (P > 0.05). CONCLUSION: Serum uric acid independently correlated with PCWP in patients with heart failure and the combined measurements of serum uric acid and plasma NT-proBNP are helpful in evaluating the prognosis of patients with heart failure. FAU - Zhang, Yu-Hui AU - Zhang YH AD - Department of Cardiology, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China. FAU - Lu, Rong AU - Lu R FAU - Zhao, Xue-Yan AU - Zhao XY FAU - Kang, Lian-Ming AU - Kang LM FAU - Yang, Yue-Jin AU - Yang YJ FAU - Zhang, Jian AU - Zhang J LA - chi PT - English Abstract PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Zhonghua Xin Xue Guan Bing Za Zhi JT - Zhonghua xin xue guan bing za zhi JID - 7910682 RN - 0 (Peptide Fragments) RN - 0 (pro-brain natriuretic peptide (1-76)) RN - 114471-18-0 (Natriuretic Peptide, Brain) RN - 268B43MJ25 (Uric Acid) RN - 9007-41-4 (C-Reactive Protein) SB - IM MH - Adolescent MH - Adult MH - Aged MH - C-Reactive Protein/*metabolism MH - Female MH - Heart Failure/*blood MH - Hemodynamics MH - Humans MH - Male MH - Middle Aged MH - Natriuretic Peptide, Brain/*blood MH - Peptide Fragments/*blood MH - Prognosis MH - Uric Acid/*blood MH - Young Adult EDAT- 2009/09/02 06:00 MHDA- 2010/01/08 06:00 CRDT- 2009/09/02 09:00 PHST- 2009/09/02 09:00 [entrez] PHST- 2009/09/02 06:00 [pubmed] PHST- 2010/01/08 06:00 [medline] PST - ppublish SO - Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Feb;37(2):126-9.